Viewing StudyNCT05722327



Ignite Creation Date: 2024-05-06 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722327
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2023-02-01

Brief Title: Phase I Trial of Adagrasib MRTX849 in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Sponsor:
Organization: MD Anderson Cancer Center